Leerink Partnrs Issues Pessimistic Outlook for ACHC Earnings

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Leerink Partnrs dropped their Q4 2025 earnings estimates for Acadia Healthcare in a report released on Thursday, November 6th. Leerink Partnrs analyst W. Mayo now expects that the company will earn $0.41 per share for the quarter, down from their previous estimate of $0.52. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. Leerink Partnrs also issued estimates for Acadia Healthcare’s Q1 2026 earnings at $0.26 EPS and Q3 2026 earnings at $0.51 EPS.

A number of other analysts have also commented on the company. Wall Street Zen raised Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Sunday, August 3rd. Royal Bank Of Canada dropped their target price on shares of Acadia Healthcare from $43.00 to $28.00 and set an “outperform” rating for the company in a research report on Wednesday, August 13th. Cowen reiterated a “buy” rating on shares of Acadia Healthcare in a research report on Thursday, August 7th. Guggenheim decreased their price target on shares of Acadia Healthcare from $29.00 to $27.00 and set a “buy” rating for the company in a research note on Monday. Finally, UBS Group cut their price objective on Acadia Healthcare from $31.00 to $28.00 and set a “buy” rating on the stock in a research report on Friday, November 7th. Eight analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $33.36.

Acadia Healthcare Price Performance

Shares of ACHC stock opened at $18.24 on Monday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.32 and a current ratio of 1.32. Acadia Healthcare has a fifty-two week low of $17.13 and a fifty-two week high of $47.08. The firm has a market cap of $1.68 billion, a P/E ratio of 12.08, a P/E/G ratio of 4.56 and a beta of 0.97. The business’s 50 day moving average price is $23.14 and its 200-day moving average price is $22.75.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.01. The company had revenue of $851.57 million for the quarter, compared to analysts’ expectations of $852.43 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.Acadia Healthcare’s quarterly revenue was up 4.4% on a year-over-year basis. During the same period last year, the firm earned $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS.

Hedge Funds Weigh In On Acadia Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Allworth Financial LP boosted its position in shares of Acadia Healthcare by 676.4% in the 2nd quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock worth $31,000 after purchasing an additional 1,177 shares in the last quarter. EverSource Wealth Advisors LLC raised its stake in Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after buying an additional 497 shares during the last quarter. Caitong International Asset Management Co. Ltd boosted its holdings in Acadia Healthcare by 11,218.2% in the first quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company’s stock worth $38,000 after acquiring an additional 1,234 shares in the last quarter. Hantz Financial Services Inc. grew its stake in shares of Acadia Healthcare by 501.9% in the third quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock worth $54,000 after acquiring an additional 1,822 shares during the last quarter. Finally, CWM LLC increased its holdings in shares of Acadia Healthcare by 105.1% during the second quarter. CWM LLC now owns 2,633 shares of the company’s stock valued at $60,000 after acquiring an additional 1,349 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.